Skip to main content
Log in

In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

We have studied the in vitro TSH secretion and the adenylate cyclase (AC) activity of a human pituitary adenoma surgically removed from a hyperthyroid patient showing high serum TSH levels. The tumor appeared almost homogeneously constituted by cells positive for an anti-TSH-beta antiserum and showing the ultrastructural characteristics of the adenomatous thyrotrophs. Adenoma fragments released in vitro a large amount of TSH (148.4 μU/mg prot/30 min), alpha-subunit(35.5 ng/mg prot/30 min) and TSH-beta (10.1 ng/mg prot/30 min). The effects of somatostatin (GHRIH) and dopamine (DA) on the hormone release have been tested in vitro. Both agents markedly inhibited the release of intact TSH and TSH-beta whereas the release of alpha-subunit was less affected. The two agents were effective at concentrations higher than 10−8M. The ability of GHRIH and DA in modulating the AC activity was investigated in membrane fraction preparations. GHRIH inhibited AC at concentrations higher than 10 −7M. The maximal inhibition was 32% at 10−5 M. Conversely, DA slightly stimulated AC activity. This effects was not mimicked by the dopaminergic ergot CH 29–717, which was completely ineffective on the enzyme. These results suggest that: 1) in this TSH-secreting pituitary adenoma a normal secretory response to the inhibiting agents (GHRIH and DA) is present; 2) different mechanisms of transduction of the GHRIH and DA signals (cAMP dependent and cAMP independent) could be operating in this tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Smallridge R.C., Wortofsky L., Dimond R.C. Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone. J. Clin. Endocrinol. Metab. 48: 700, 1979.

    Article  PubMed  CAS  Google Scholar 

  2. Faglia G., Beck Peccoz P., Piscitelli G., Spada A. Clinical aspects and treatment of TSH-secreting pituitary adenomas and non neoplastic inappropriate secretion of TSH. In: Lamberts S.W.J., Tilders F.J.H., Van der Veen E.A., Assies J. (Eds.), Trends in diagnosis and treatment of pituitary adenomas. Free-University Press, Amsterdam, 1984, p. 273.

    Google Scholar 

  3. Tolis G., Bird C., Bertrand G., Mackenzie J.M., Ezrin C. Pituitary hyperthyroidism. Am. J. Med. 64: 177, 1978.

    Article  PubMed  CAS  Google Scholar 

  4. Kourides I.A., Ridgway E.C., Weintraub B.D., Bigos S.T., Gershengorn M.C., Maloof E. Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J. Clin. Endocrinol. Metab. 45: 534, 1977.

    Article  PubMed  CAS  Google Scholar 

  5. Smallridge R.C., Smith C.E. Hyperthyroidism due to thyrotropin secreting pituitary tumors. Diagnostic and therapeutic considerations. Arch. Intern. Med. 143: 503, 1983.

    Article  PubMed  CAS  Google Scholar 

  6. Benoit R., Pearson-Murphy B.E., Robert F., Marcovitz S., Hardy J., Tsoukas G., Gardiner B.J. Hyperthyroidism due to a pituitary TSH secreting tumor with amenorrhea-galactorrhea. Clin. Endocrinol. (Oxf.) 12: 11, 1980.

    Article  CAS  Google Scholar 

  7. Siler T.M., Yen S.S.C., Vale W., Guillemin R. Inhibition by somatostatin on the release of TSH induced in man by thyrotropin releasing factor. J. Clin. Endocrinol. Metab. 38: 742, 1974.

    Article  PubMed  CAS  Google Scholar 

  8. Healy D.L., Burger H.G. Increased prolactin and thyrotropin secretion following oral metoclopramide: dose response relationship. Clin. Endocrinol. (Oxf.) 7: 195, 1977.

    Article  CAS  Google Scholar 

  9. Horn K., Erhardt F., Fahlbush R., Pickardt C.R., Von Werder K., Scriba P.C. Recurrent goiter, galactorrhea and amenorrhea due to thyrotropin and prolactin producing pituitary tumor. J. Clin. Endocrinol. Metab. 43: 137, 1976.

    Article  PubMed  CAS  Google Scholar 

  10. Werner S. Human pituitary adenomas with hypersecretion of TSH and prolactin: evidence that receptor sites for dopamine may be present on TSH-producing while present on prolactin-producing cells. Horm. Metab. Res. 11: 452, 1979.

    Article  PubMed  CAS  Google Scholar 

  11. Filetti S., Rapoport B., Aron D.C., Greenspan F.C., Wilson C.B., Fraser W. TSH and TSH-subunit production by human thyrotropic tumour cells in monolayer culture. Acta Endocrinol. (Kbh.) 99: 224, 1982.

    CAS  Google Scholar 

  12. Lamberts S.W.J., Oosterom R., Verleun T., Krenning E.P., Assies H. Regulation of hormone release by cultured cells from a thyrotropin-growth hormone secreting pituitary tumor. Direct inhibitory effects of 3,5,3′-triiodothyronine and dexamethasone on thyrotropin secretion. J. Endocrinol. Invest. 7: 313, 1984.

    Article  PubMed  CAS  Google Scholar 

  13. Giannattasio G., De Ferrari M.E., Spada A. Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. Life Sci. 28: 1605, 1981.

    Article  PubMed  CAS  Google Scholar 

  14. Swennen L., Denef C. Physiological concentrations of dopamine decrease adenosine 3′–5′ monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs. Evidence for causal relationship to inhibition of prolactin release. Endocrinology 111: 393, 1982.

    Article  Google Scholar 

  15. Spada A., Vallar L., Giannattasio G. Presence of an adenylate cyclase dually regulated by somatostatin and human pancreatic GH releasing factor in GH-secreting cells. Endocrinology, 115: 1203, 1984.

    Article  PubMed  CAS  Google Scholar 

  16. Spada A., Nicosia S., Cortelazzi L., Pezzo G., Bassetti M., Sartorio A., Giannattasio G. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro- and microadenomas to dopamine and vasoactive intestinal polypeptide. J. Clin. Endocrinol. Metab. 56: 1, 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265, 1951.

    PubMed  CAS  Google Scholar 

  18. Salomon Y., Londos C., Rodbell M.A. A highly sensitive adenylate cyclase assay. Annal. Biochem. 58: 541, 1974.

    Article  CAS  Google Scholar 

  19. Faglia G., Beck Peccoz P., Ferrari C., Travaglini P., Ambrosi B. Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J. Clin. Endocrinol. Metab. 37: 595, 1973.

    Article  PubMed  CAS  Google Scholar 

  20. Faglia G., Beck Peccoz P., Ballabio M., Nava C. Excess of beta-subunit of thyrotropin (TSH) in patients with idiopathic central hypothyroidism due to the secretion of TSH with reduced biological activity. J. Clin. Endocrinol. Metab. 56: 908, 1983.

    Article  PubMed  CAS  Google Scholar 

  21. Mosca L., Solcia E., Capella C., Buffa R. Pituitary adenomas: surgical versus post mortem findings today. In: Faglia G., Giovannelli M.A., MacLeod R.M. (Eds.), Pituitary Microadenomas. Academic Press, London, 1980, p. 137.

    Google Scholar 

  22. Mashiter K., Van Noorden S., Fahlbush R., Fill H., Skrabal K. Hyperthyroidism due to a TSH secreting pituitary adenoma: case report, treatment and evidence for adenoma TSH by morphological and cell culture studies. Clin. Endocrinol. (Oxf.) 18: 473, 1983.

    Article  CAS  Google Scholar 

  23. Blackman M.R., Gershengorn M.C., Weintraub B.D. Excess production of free alpha subunit by mouse pituitary thyrotropic tumor cells in vitro. Endocrinology 102: 499, 1978.

    Article  PubMed  CAS  Google Scholar 

  24. Vale W., Rivier C., Brazeau P., Guillemin R. Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology 95: 968, 1974.

    Article  PubMed  CAS  Google Scholar 

  25. Foord S.M., Peters J., Scanion F., Rees Smith B., Hall R. Dopaminergic control of TSH secretion in isolated rat pituitary cells. FEBS Lett. 121: 257, 1980.

    Article  PubMed  CAS  Google Scholar 

  26. Foord S.M., Peters J.R., Dieguez C., Scanlon M.F., Hall R. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Endocrinology 112: 1567, 1983.

    Article  PubMed  CAS  Google Scholar 

  27. Labrie F., Pelletier G., Borgeat P., Drouin J., Ferland L., Belanger A. Mode of action of hypothalamic regulatory hormones in the adenohypophysis. In: Martini L. and Ganong W.F. (Eds.), Frontiers in Neuroendocrinology. Raven Press, New York, 1976, vol.4, p. 63.

    CAS  Google Scholar 

  28. Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature 227: 93, 1979.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spada, A., Bassetti, M., Martino, E. et al. In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine. J Endocrinol Invest 8, 193–198 (1985). https://doi.org/10.1007/BF03348476

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348476

Key-words

Navigation